Inventor · disambiguated record
John J. Rossi
Also filed as: ROSSI JOHN · ROSSI JOHN J
102 granted patents·49 pending applications·1,510 citations·filing 1987–2024
99Inventor score
Files withHOPE CITY111ROSSI JOHN J18INTEGRATED DNA TECH INC7CALIFORNIA INST OF TECHN4CALANDO PHARMACEUTICALS INC2
Top patents by PatentIndex Score
151 records- 0199US8084599B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAROSSI JOHN J·Filed 2005·Granted Dec 27, 2011·106 cites·148 claims
- 0298US8883996B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAROSSI JOHN J·Filed 2012·Granted Nov 11, 2014·48 cites·25 claims
- 0397US8691786B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAHOPE CITY·Filed 2013·Granted Apr 8, 2014·24 cites·61 claims
- 0496US7427605B2Inhibitors of ribonucleotide reductase subunit 2 and uses thereofCALANDO PHARMACEUTICALS INC·Filed 2006·Granted Sep 23, 2008·382 cites·14 claims
- 0595US9605266B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2015·Granted Mar 28, 2017·24 cites·12 claims
- 0693US8030290B2Cell-type specific aptamer-siRNA delivery system for HIV-1 TherapyHOPE CITY·Filed 2008·Granted Oct 4, 2011·13 cites·5 claims
- 0792US8222226B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyROSSI JOHN J·Filed 2011·Granted Jul 17, 2012·9 cites·18 claims
- 0892US5144019ARibozyme cleavage of HIV-I RNAHOPE CITY·Filed 1989·Granted Sep 1, 1992·192 cites·3 claims
- 0991US10167474B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2017·Granted Jan 1, 2019·6 cites·18 claims
- 1090US11643659B2Conditional-siRNAS and uses thereof in treating acute myeloid leukemiaHOPE CITY·Filed 2020·Granted May 9, 2023·2 cites·16 claims
- 1189US10550394B2Anti-cancer RNA aptamersHOPE CITY·Filed 2016·Granted Feb 4, 2020·4 cites·27 claims
- 1289US9506064B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyHOPE CITY·Filed 2015·Granted Nov 29, 2016·3 cites·19 claims
- 1389US6995258B1Nucleolar targeting of therapeutics against HIVHOPE CITY·Filed 2001·Granted Feb 7, 2006·30 cites·9 claims
- 1488US9725715B2Signal activatable constructs and related components compositions methods and systemsCALIFORNIA INST OF TECHN·Filed 2015·Granted Aug 8, 2017·5 cites·21 claims
- 1588US9688982B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2013·Granted Jun 27, 2017·7 cites·4 claims
- 1688US9388418B2Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their useHOPE CITY·Filed 2014·Granted Jul 12, 2016·12 cites·11 claims
- 1788US8916696B2Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their useROSSI JOHN J·Filed 2012·Granted Dec 23, 2014·12 cites·7 claims
- 1887US11208654B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 1987US8748405B2Methods and compositions for the treatment of cancer or other diseasesYU HUA·Filed 2011·Granted Jun 10, 2014·7 cites·3 claims
- 2086US10253318B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2017·Granted Apr 9, 2019·3 cites·14 claims
- 2186US9206419B2Targeting domain and related signal activated molecular deliveryCALIFORNIA INST OF TECHN·Filed 2013·Granted Dec 8, 2015·5 cites·23 claims
- 2286US6562570B1Method for identifying accessible binding sites on RNAHOPE CITY·Filed 2000·Granted May 13, 2003·19 cites·18 claims
- 2386US6100087ARibozymes targeted to human CCR5 mRNAHOPE CITY·Filed 1998·Granted Aug 8, 2000·87 cites·9 claims
- 2485US9464293B2RNA aptamers for therapeutic and diagnostic delivery to pancreatic cancer cellsHOPE CITY·Filed 2013·Granted Oct 11, 2016·7 cites·15 claims
- 2585US9163241B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyROSSI JOHN J·Filed 2011·Granted Oct 20, 2015·3 cites·11 claims
- 2685US9115355B2Exonuclease resistant polynucleotide and related duplex polynucleotides, constructs, compositions, methods and systemsCALIFORNIA INST OF TECHN·Filed 2013·Granted Aug 25, 2015·5 cites·26 claims
- 2785US8710199B2Signal activated molecular deliveryHAN SI-PING·Filed 2011·Granted Apr 29, 2014·6 cites·33 claims
- 2884US11999954B2Programmable conditional SIRNAS and uses thereofHOPE CITY·Filed 2021·Granted Jun 4, 2024·1 cites·11 claims
- 2984US9200280B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·4 cites·3 claims
- 3083US10519442B2Twist signaling inhibitor compositions and methods of using the sameHOPE CITY·Filed 2017·Granted Dec 31, 2019·2 cites·26 claims
- 3183US5110802AOligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonatesHOPE CITY·Filed 1987·Granted May 5, 1992·57 cites·5 claims
- 3282US11261449B2Anti-cancer RNA aptamersHOPE CITY·Filed 2019·Granted Mar 1, 2022·1 cites·15 claims
- 3382US9441227B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAHOPE CITY·Filed 2014·Granted Sep 13, 2016·2 cites·48 claims
- 3482US5622820AMethod for amplification and detection of RNA and DNA sequencesHOPE CITY·Filed 1994·Granted Apr 22, 1997·67 cites·16 claims
- 3581US10041071B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyHOPE CITY·Filed 2016·Granted Aug 7, 2018·1 cites·26 claims
- 3681US7820632B2Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such moleculesHOPE CITY·Filed 2003·Granted Oct 26, 2010·6 cites·20 claims
- 3781US6379931B1Chimeric DNA/RNA ribozymes containing propanediolHOPE CITY·Filed 2000·Granted Apr 30, 2002·8 cites·7 claims
- 3881US5149796AChimeric DNA-RNA catalytic sequencesHOPE CITY·Filed 1991·Granted Sep 22, 1992·74 cites·3 claims
- 3979US11219635B2Bi-specific aptamerHOPE CITY·Filed 2017·Granted Jan 11, 2022·1 cites·21 claims
- 4079US8796444B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAROSSI JOHN J·Filed 2011·Granted Aug 5, 2014·1 cites·102 claims
- 4179US2023193258A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2021·Application pending·0 cites
- 4278US11104902B2Splice inhibiting oligonucleotidesHOPE CITY·Filed 2018·Granted Aug 31, 2021·1 cites·18 claims
- 4378US8658356B2Methods and compositions for the specific inhibition of gene expression by double-stranded RNAROSSI JOHN J·Filed 2011·Granted Feb 25, 2014·1 cites·80 claims
- 4478US5272262AMethod for the production of catalytic RNA in bacteriaHOPE CITY·Filed 1990·Granted Dec 21, 1993·64 cites·11 claims
- 4577US4874853ASynthetic oligonucleotides useful in diagnosis of chronic myelogenous leukemiaHOPE CITY·Filed 1988·Granted Oct 17, 1989·48 cites·4 claims
- 4676US11926826B2Twist signaling inhibitor compositions and methods of using the sameHOPE CITY·Filed 2022·Granted Mar 12, 2024·0 cites·24 claims
- 4776US8138327B2Inducible systems and methods for controlling siRNA expressionUNWALLA HOSHANG·Filed 2005·Granted Mar 20, 2012·5 cites·30 claims
- 4875US8791082B2Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferonROSSI JOHN J·Filed 2007·Granted Jul 29, 2014·1 cites·3 claims
- 4975US2024401043A1Programmable conditional sirnas and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 5074US12138279B2Bi specific aptamerHOPE CITY·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John J. Rossi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →